Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Colon Carcinoma: early-phase trial registry

1 of 8 indexed Colon Carcinoma trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,176 of 28,707 conditions by registered trial count.

8 US clinical trials · 1 currently recruiting · #2,176 of 28,707 conditions by registered trial count

Colon Carcinoma: 8 US clinical trials tracked, 1 recruiting.

Colon Carcinoma is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is City of Hope Medical Center, running 2 of these trials.

Enrollment posture brief

Registry condition colon-carcinoma

OPEN 1 | RECR 13% | LATE 0 | EARLY 5 | RANK #2176 | SPON 2

Nearest open-share peer: Acute Respiratory Infection (13% recruiting · 8 trials)

Activity, Motor75%Achalasia50%Abdominal Cancer25%Acne Scars - Mixed Atrophic 25%Colon Carcinoma (this)13%
Open-enrollment share among volume-matched conditions near Colon Carcinoma

Colon Carcinoma lists 1 open slots (13% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Colon Carcinoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Colon Carcinoma is recruiting below its size-band peers.

    1 of 8 indexed trials (12.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Colon Carcinoma research.

    City of Hope Medical Center accounts for 2 of 8 trials (25%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical Colon Carcinoma enrolment sits around 120 participants.

    Median target enrolment is 120 among the 8 trials that report a genuine target (sentinel values excluded). 4 of those (50%) plan for fewer than 100 participants.

  4. Colon Carcinoma research is mostly interventional.

    8 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 13Phase 22

Open and recent trials

8 total, page 1 of 1

RECRUITING Phase 2 120 participants

Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors

City of Hope Medical Center

NCT06731894

ACTIVE NOT RECRUITING NA 154,900 participants

Screening for Colorectal Cancer in Older Patients (PLCO Screening Trial)

National Cancer Institute (NCI)

NCT01696981

ACTIVE NOT RECRUITING Phase 2 6,452 participants

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

National Cancer Institute (NCI)

NCT02465060

ACTIVE NOT RECRUITING NA 146 participants

Lesion Detection Assessment in the Liver: Standard vs Low Radiation Dose Using Varied Post-Processing Techniques

M.D. Anderson Cancer Center

NCT03151564

ACTIVE NOT RECRUITING Early Phase 1 29 participants

Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues

Jonsson Comprehensive Cancer Center

NCT04147494

ACTIVE NOT RECRUITING Phase 1 11 participants

Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy

City of Hope Medical Center

NCT02432963

COMPLETED Phase 1 15 participants

Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer)

Barbara Ann Karmanos Cancer Institute

NCT01420874

COMPLETED NA 6 participants

Clinical Outcomes for Offering Genetic Testing in a Tiered Approach

Fred Hutchinson Cancer Center

NCT04902144

Phase Distribution

PhaseTrial count
Phase 1 3
Phase 2 2

Named interventions

Most-linked intervention names on Colon Carcinoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

EGFRBi armed ATC Infusions Biological
1 trials
FOLFOX6 Drug
1 trials
18F-FDG Radiation
1 trials
Gallium Ga 68-labeled PSMA-11 Radiation
1 trials
Deep Learning Image Reconstruction (DLIR) Diagnostic test
1 trials
Computed Tomography Scan - 70% Dose Reduction Diagnostic test
1 trials
Computed Tomography Scan - 50% Dose Reduction Diagnostic test
1 trials
Adavosertib Drug
1 trials

US sites by state

Facility locations filed on Colon Carcinoma trials. A trial with sites in several states counts in each.

California 3 trials
Washington 1 trials
Texas 1 trials
Michigan 1 trials
Maryland 1 trials
Arizona 1 trials
Alabama 1 trials
Alaska 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Colon Carcinoma page

8 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Colon Carcinoma condition card totals 8 registered trials; most-linked intervention EGFRBi armed ATC Infusions; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.